HRP20070081T5 - Nazalni farmaceutski pripravak piribedila - Google Patents

Nazalni farmaceutski pripravak piribedila

Info

Publication number
HRP20070081T5
HRP20070081T5 HR20070081T HRP20070081T HRP20070081T5 HR P20070081 T5 HRP20070081 T5 HR P20070081T5 HR 20070081 T HR20070081 T HR 20070081T HR P20070081 T HRP20070081 T HR P20070081T HR P20070081 T5 HRP20070081 T5 HR P20070081T5
Authority
HR
Croatia
Prior art keywords
piribedil
pharmaceutical composition
nasal pharmaceutical
pharmaceutically acceptable
nasal
Prior art date
Application number
HR20070081T
Other languages
English (en)
Inventor
Rolland Herv
Wuthrich Patrick
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20070081T3 publication Critical patent/HRP20070081T3/hr
Publication of HRP20070081T5 publication Critical patent/HRP20070081T5/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Farmaceutski pripravak u obliku vodene otopine ili praška za nazalnu primjenu piribedila, naznačen time, da sadrži: - piribedil ili njegovu farmaceutski prihvatljivu sol, - opcionalno ciklodekstrin, i- jedan ili više farmaceutski prihvatljivih ekscipijensa. Patent sadrži još 5 patentnih zahtjeva.
HR20070081T 2003-07-17 2007-02-28 Nazalni farmaceutski pripravak piribedila HRP20070081T5 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308712A FR2857594B1 (fr) 2003-07-17 2003-07-17 Composition pharmaceutique pour l'administration par voie nasale de piribedil
PCT/FR2004/001867 WO2005009442A1 (fr) 2003-07-17 2004-07-16 Composition pharmaceutique pour l’administration par voie nasale de piribedil

Publications (2)

Publication Number Publication Date
HRP20070081T3 HRP20070081T3 (hr) 2007-04-30
HRP20070081T5 true HRP20070081T5 (hr) 2007-08-31

Family

ID=33548200

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070081T HRP20070081T5 (hr) 2003-07-17 2007-02-28 Nazalni farmaceutski pripravak piribedila

Country Status (30)

Country Link
US (1) US20060204449A1 (hr)
EP (1) EP1653963B1 (hr)
JP (1) JP2007516947A (hr)
KR (1) KR100807480B1 (hr)
CN (1) CN100540004C (hr)
AR (1) AR046808A1 (hr)
AT (1) ATE349213T1 (hr)
AU (1) AU2004258714A1 (hr)
BR (1) BRPI0412681A (hr)
CA (1) CA2532631C (hr)
CY (1) CY1106013T1 (hr)
DE (1) DE602004003955T2 (hr)
DK (1) DK1653963T3 (hr)
EA (1) EA011041B1 (hr)
ES (1) ES2279435T3 (hr)
FR (1) FR2857594B1 (hr)
GE (1) GEP20074259B (hr)
HK (1) HK1094153A1 (hr)
HR (1) HRP20070081T5 (hr)
MA (1) MA27864A1 (hr)
MX (1) MXPA06000641A (hr)
MY (1) MY137747A (hr)
NO (1) NO332776B1 (hr)
NZ (1) NZ544460A (hr)
PL (1) PL1653963T3 (hr)
PT (1) PT1653963E (hr)
SI (1) SI1653963T1 (hr)
UA (1) UA85193C2 (hr)
WO (1) WO2005009442A1 (hr)
ZA (1) ZA200600240B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ590291A (en) * 2008-06-06 2013-11-29 Pharma Two B Ltd Pharmaceutical compositions for treatment of parkinson's disease
WO2014141280A1 (en) * 2013-03-13 2014-09-18 Abital Pharma Pipelines Ltd. Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
IT201800005117A1 (it) * 2018-05-07 2019-11-07 Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
WO1994022445A2 (en) * 1993-03-26 1994-10-13 Merkus Franciscus W H M Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine
FR2710268B1 (fr) * 1993-09-22 1995-10-20 Adir Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
AU750361B2 (en) * 1997-03-26 2002-07-18 Franciscus W.H.M. Merkus Nasal melatonin composition
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
US20020002175A1 (en) * 2000-09-19 2002-01-03 Charanjit Behl Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) * 2001-06-25 2004-02-12 Nastech Pharmaceutical Company Inc Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

Also Published As

Publication number Publication date
MA27864A1 (fr) 2006-04-03
UA85193C2 (ru) 2009-01-12
PT1653963E (pt) 2007-02-28
HK1094153A1 (en) 2007-03-23
CN1819828A (zh) 2006-08-16
CA2532631C (fr) 2011-01-04
EP1653963B1 (fr) 2006-12-27
MY137747A (en) 2009-03-31
DE602004003955D1 (de) 2007-02-08
NZ544460A (en) 2008-04-30
NO20060743L (no) 2006-02-16
AU2004258714A1 (en) 2005-02-03
MXPA06000641A (es) 2006-03-30
EA200600172A1 (ru) 2006-06-30
HRP20070081T3 (hr) 2007-04-30
KR100807480B1 (ko) 2008-02-25
US20060204449A1 (en) 2006-09-14
FR2857594A1 (fr) 2005-01-21
GEP20074259B (en) 2007-12-10
BRPI0412681A (pt) 2006-10-03
KR20060031689A (ko) 2006-04-12
FR2857594B1 (fr) 2005-09-16
ZA200600240B (en) 2007-03-28
DK1653963T3 (da) 2007-04-10
EP1653963A1 (fr) 2006-05-10
CY1106013T1 (el) 2011-04-06
ES2279435T3 (es) 2007-08-16
DE602004003955T2 (de) 2007-12-06
CA2532631A1 (fr) 2005-02-03
NO332776B1 (no) 2013-01-14
PL1653963T3 (pl) 2007-02-28
JP2007516947A (ja) 2007-06-28
AR046808A1 (es) 2005-12-28
CN100540004C (zh) 2009-09-16
SI1653963T1 (sl) 2007-04-30
EA011041B1 (ru) 2008-12-30
WO2005009442A1 (fr) 2005-02-03
ATE349213T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
HRP20060240T3 (hr) Intranazalni pripravak rotigotina
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
HRP20041152B1 (hr) Farmaceutske formulacije
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
RS52367B (en) GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES
RS52831B (en) THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
CR7362A (es) Formulaciones farmaceuticas de derivado de platino
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
CY1108676T1 (el) Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων
SE0101932D0 (sv) Pharmaceutical combinations
ATE541562T1 (de) Ibuprofen-suspension
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
HRP20070291T3 (hr) Farmaceutski sastav koji sadrži kompleks cink-hijaluronata za liječenje multiple skleroze
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
DE602004023093D1 (de) N mit einem abgabemittel in mikronisierter form
BRPI0417350A2 (pt) composiÇço para a distribuiÇço nasal, uso de granisetron ou de um sal farmaceuticamente aceitÁvel do mesmo, e quitosana, um sal, um derivado ou sal de um derivado do mesmo, mÉtodos de administraÇço de granisetron ou de um sal farmaceuticamente aceitÁvel do mesmo, e de tratamento ou prevenÇço de nÁusea e/ou vâmito, e, dispositivo para a distribuiÇço da droga nasal ou um cartucho de dose
HRP20070081T3 (hr) Nazalni farmaceutski pripravak piribedila
SE0001916D0 (sv) Novel formulation
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса